Evidence map›Paper›PMID 31054120›Full record

SynthesisJournal of thrombosis and thrombolysis2019

Dual versus triple therapy for patients with atrial fibrillation and acute coronary syndrome: a meta-analysis and trial sequential analysis of randomized controlled trials.

Babikir Kheiri, Mohammed Osman, Ahmed Bakhit, Qais Radaideh, Ahmed Abdalla, Mahmoud Barbarawi, Yazan Zayed, Sahar Ahmed, Ghassan Bachuwa, Mustafa Hassan

Abstract readLetterMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in Journal of thrombosis and thrombolysis, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Babikir KheiriDepartment of Internal Medicine, Hurley Medical Center, Michigan State University, Two Hurley Plaza, Suite 212, Flint, MI, 48503, USA. bkheiri1@hurleymc.com.ORCID 0000-0003-1747-2859
Mohammed OsmanDivision of Cardiology, West Virginia University School of Medicine, Morgantown, WV, USA.
Ahmed BakhitDivision of Cardiology, Saint Vincent Hospital, Worcester, MA, USA.
Qais RadaidehMidwest Cardiovascular Research Foundation, Davenport, IA, USA.
Ahmed AbdallaDivision of Hematology & Oncology, St. John Hospital, Grosse Pointe Woods, MI, 48236, USA.
Mahmoud BarbarawiDepartment of Internal Medicine, Hurley Medical Center, Michigan State University, Two Hurley Plaza, Suite 212, Flint, MI, 48503, USA.
Yazan ZayedDepartment of Internal Medicine, Hurley Medical Center, Michigan State University, Two Hurley Plaza, Suite 212, Flint, MI, 48503, USA.
Sahar AhmedDepartment of Internal Medicine, Hurley Medical Center, Michigan State University, Two Hurley Plaza, Suite 212, Flint, MI, 48503, USA.
Ghassan BachuwaDepartment of Internal Medicine, Hurley Medical Center, Michigan State University, Two Hurley Plaza, Suite 212, Flint, MI, 48503, USA.
Mustafa HassanDivision of Cardiology, Hurley Medical Center, Michigan State University, Flint, MI, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acute Coronary SyndromeAnticoagulantsAtrial FibrillationDrug Therapy, CombinationHumansPlatelet Aggregation InhibitorsRandomized Controlled Trials as TopicAnticoagulantsPlatelet Aggregation Inhibitors

Identifiers

PMID31054120

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.